Ausgabe 1/2017
Inhalt (12 Artikel)
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
Supritha G. Swamy, Vivek H. Kameshwar, Priya B. Shubha, Chung Yeng Looi, Muthu K. Shanmugam, Frank Arfuso, Arunasalam Dharmarajan, Gautam Sethi, Nanjunda Swamy Shivananju, Anupam Bishayee
The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences
Estelle Willems, Arnaud Lombard, Matthias Dedobbeleer, Nicolas Goffart, Bernard Rogister
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
I. Duran, J. Lambea, P. Maroto, J. L. González-Larriba, Luis Flores, S. Granados-Principal, M. Graupera, B. Sáez, A. Vivancos, O. Casanovas
New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate Cancer
Isabel Heidegger, Axel Heidenreich, David Pfister
mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review
Cara M. Statz, Sara E. Patterson, Susan M. Mockus
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma
Giovan Giuseppe Di Costanzo, Raffaella Tortora, Filomena Morisco, Luigi Addario, Maria Guarino, Gabriella Cordone, Luigia Falco, Nicola Caporaso
Effect of Targeting Clusterin Using OGX-011 on Antitumor Activity of Temsirolimus in a Human Renal Cell Carcinoma Model
Masatomo Nishikawa, Hideaki Miyake, Martin Gleave, Masato Fujisawa
Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis and Literature Review
Xiaoli Zhu, Qianming Bai, Yongming Lu, Peng Qi, Jianhui Ding, Jialei Wang, Xiaoyan Zhou
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
Katerina Kopeckova, Tomas Buchler, Zbynek Bortlicek, Karel Hejduk, Renata Chloupkova, Bohuslav Melichar, Petra Pokorna, Jiri Tomasek, Zdenek Linke, Lubos Petruzelka, Igor Kiss, Jana Prausova
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
Jean-Luc Van Laethem, Hanno Riess, Jacek Jassem, Michael Haas, Uwe M. Martens, Colin Weekes, Marc Peeters, Paul Ross, John Bridgewater, Bohuslav Melichar, Stefano Cascinu, Piotr Saramak, Patrick Michl, David Van Brummelen, Alberto Zaniboni, Wollf Schmiegel, Svein Dueland, Marius Giurescu, Vittorio L. Garosi, Katrin Roth, Anke Schulz, Henrik Seidel, Prabhu Rajagopalan, Michael Teufel, Barrett H. Childs
Adjusting Overall Survival Estimates after Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate Cancer
Konstantina Skaltsa, Cristina Ivanescu, Shevani Naidoo, De Phung, Stefan Holmstrom, Nicholas R. Latimer
Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
Mario Scartozzi, Loic Vincent, Marielle Chiron, Stefano Cascinu